Business Context and Reporting Period
This Form 8-K Current Report was filed by Shuttle Pharmaceuticals Holdings, Inc. (SHPH) on March 22, 2023, covering events occurring between March 16 and March 22, 2023. The Company is an emerging growth company focused on developing small molecule radiation sensitizers and immune activation candidates.
Key Financial Metrics
This filing does not contain a comprehensive financial statement. However, it references specific financial figures related to recent capital raises and a new contract:
- New Contract Value: A Research Agreement with Georgetown University has a total estimated cost of $128,400.
- Recent Capital Raises: The Company completed an initial public offering of approximately $11.4 million in September 2022 and a private placement of $4.0 million in January 2023.
- Revenue, Profit, and Cash Flow: The filing text does not provide current revenue, profit, cash flow, or margin data.
Material Changes
The filing reports two primary material changes:
- Research Partnership: On March 16, 2023, the Company entered into a one-year Research Agreement with Georgetown University to test its drug candidates in cell-based and animal xenograft models. A related Material Transfer Agreement was executed on March 21, 2023.
- Change in Auditor: On March 21, 2023, the Company replaced its independent registered public accounting firm. BF Borgers CPA PC was dismissed, and FORVIS LLP was selected to serve as the new auditor for the 2023 fiscal year.
Outlook, Risks, and Management Commentary
Resolution of Going Concern Uncertainty: The former auditor had issued a "Going Concern Opinion" for the year ended December 31, 2021, citing uncertainty about the Company's ability to continue operations. Management notes this uncertainty was resolved following the completion of the $11.4 million IPO and the $4.0 million private placement.
Disagreements: The Company reported no disagreements with the former accountant regarding accounting principles, financial statement disclosures, or auditing scope for the years ended December 31, 2021 and 2022.
Investor Communications: On March 22, 2023, the Company posted an updated investor presentation and issued a press release regarding the Georgetown University agreement.
Key Facts for Investor Verification
- Verify the terms and milestones of the $128,400 Research Agreement with Georgetown University (Exhibit 10.1).
- Confirm the transition timeline and scope of work for the new auditor, FORVIS LLP.
- Review the updated investor presentation (Exhibit 99.1) for the latest strategic roadmap and cash runway projections.
- Monitor future filings for the first financial statements audited by FORVIS LLP to confirm the sustained resolution of the going concern issue.